SAPIGNI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 575
EU - Europa 170
AS - Asia 24
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 774
Nazione #
US - Stati Uniti d'America 575
IE - Irlanda 54
SE - Svezia 46
IT - Italia 37
GB - Regno Unito 21
SG - Singapore 12
BE - Belgio 9
IN - India 8
EU - Europa 3
CN - Cina 2
PT - Portogallo 2
AR - Argentina 1
BR - Brasile 1
FI - Finlandia 1
JP - Giappone 1
TR - Turchia 1
Totale 774
Città #
Des Moines 140
Chandler 127
Dublin 52
Ashburn 45
Boardman 21
Boydton 17
Fairfield 17
New York 16
Lawrence 13
Princeton 13
Cambridge 12
Wilmington 11
Brussels 9
Pune 8
San Mateo 8
Centro 7
Menlo Park 7
Woodbridge 7
San Diego 6
Seattle 6
Turin 6
Huskvarna 5
Houston 4
London 4
Rome 4
Washington 4
Ann Arbor 3
Ascoli Piceno 3
Kilburn 3
Redmond 3
Acton 2
Ancona 2
Lisbon 2
New Bedfont 2
Novara 2
Prescot 2
Shanghai 2
Southwark 2
Andover 1
Bergamo 1
Caserta 1
Civitanova Marche 1
Emet 1
Fremont 1
Helsinki 1
Norwalk 1
Ramos Mejia 1
Totale 606
Nome #
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 70
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 68
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 64
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 64
Buschke–ollendorff syndrome in a 6-year old patient: Clinical anhistopathological aspects of a rare disease 62
Reticulated acanthoma with sebaceous differentiation 54
Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: A controlled retrospective clinical study 54
Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance 52
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 50
The effect of dupilumab in an HBV-HIV coinfected atopic patient: a case report 48
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study. 37
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa 31
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 28
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study 27
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 19
Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa 18
Successful use of dalbavancin in the management of severe hidradenitis suppurativa 17
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis 12
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 11
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 7
Bimekizumab in hidradenitis suppurativa: a valid and rapid emerging treatment 6
Totale 799
Categoria #
all - tutte 4.984
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.984


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 32 9
2021/2022116 10 8 0 0 4 8 1 6 10 0 22 47
2022/2023438 28 38 21 36 12 174 0 12 65 4 32 16
2023/2024204 37 6 28 32 39 44 5 13 0 0 0 0
Totale 799